Health Stock 'Looking Set to Bounce Back After 90% Drop'
Source: Clive Maund for Streetwise Reports  (12/11/18)
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. More >

Neuromonitoring Stock 'Ready to Rally'
Source: Clive Maund for Streetwise Reports  (11/26/18)
Technical analyst Clive Maund charts a neuromonitoring company that he believes is undervalued. More >

Biotech Files Patent Application for Nitric Oxide Delivery Device
Source: Streetwise Reports  (11/16/18)
With this development, the company advances blood/plasma transfusion technology.
More >

Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements
Source: Streetwise Reports  (10/9/18)
This Utah-based company rolled out an online campaign that highlights its strategic repositioning. More >

Company with Cancer Radiotherapy Grows Revenue for Six Consecutive Quarters
Source: Streetwise Reports  (10/3/18)
An H.C. Wainwright & Co. report reviewed this company's Q4/18 earnings and opportunities for increasing it. More >

Surgical Robotics Developer Demonstrates Technology at Medical Conference
Source: Streetwise Reports  (10/3/18)
A Ladenburg Thalmann report relayed how this Massachusetts company participated at the Transcatheter Cardiovascular Therapeutics annual meeting through a live transmission—the first ever—of a remote interventional procedure using the CorPath GRX system. More >

Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device
Source: Streetwise Reports  (9/5/18)
A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. More >

Medical Device Firm Anticipates Benefit from Patent Ruling
Source: Streetwise Reports  (8/15/18)
This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent. More >

Medical Device Firm's Clinical Programs Progress in Q2/18
Source: Streetwise Reports  (8/15/18)
A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence. More >

Interim Readout for Pharma Trial 'Delivers Home Run'
Source: Streetwise Reports  (7/31/18)
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. More >

Agreement Facilitates Progress Toward Medical Device Approvals
Source: Streetwise Reports  (6/20/18)
This medical device company enters a partnership to provide quality and regulatory services. More >

Coverage Initiated on Developer of Women's Reproductive Health Products
Source: Streetwise Reports  (5/30/18)
A ROTH Capital Partners research report outlined the key drivers of the investment thesis for this firm. More >

Analyst: 'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'
Source: Streetwise Reports  (5/23/18)
Cowen analyst Dr. Joshua Jennings highlighted this medical device firm's Q1/18 developments and financial results. More >

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease
Source: Streetwise Reports  (5/2/18)
In the second of a two-part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small-cap companies targeting big-ticket indications and their potential to drive blockbuster value for both patients and investors. More >

Medical Device Firm Posts 'Strong Performance' Globally in Q4/17
Source: Streetwise Reports   (3/28/18)
The company performed strongly in the U.S. and the Asia Pacific region. More >

Convergence Will Drive the Ultimate Disruption of Life Sciences
Source: Andrea Bartzen for Streetwise Reports  (3/28/18)
Andrea Bartzen, a strategic commercial and communication consultant, describes the disruptive technologies positioned to radically alter the business of life sciences as discussed at a recent BIO CEO Summit Investor Night.
More >

Medical Device Firm to Launch Trials for Treatment Targeting $12 Billion Incontinence Market
Source: Streetwise Reports  (2/14/18)
Anthony Vendetti, an analyst with Maxim Group, shared the results both of a pilot study for stress urinary incontinence and of a recent equity raise by this company.
More >

Medical Device Firm Boosts Quarterly Revenue 50% YOY
Source: Streetwise Reports  (1/31/18)
A Maxim Group report noted the recently announced revenue achieved and anticipated by this producer of cancer treatment devices. More >

Firm Focused on Women's Health Posts 'Record' Sales of Treatment Device
Source: Streetwise Reports  (1/10/18)
A company marketing a product designed to enhance women's sexual function announced preliminary financial results for Q4/17 that caught the attention of several analysts. More >

Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA
Source: Streetwise Reports  (12/27/17)
Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients undergoing heart surgery and will measure its effectiveness in reducing a common post-surgical side effect.
More >

Analysts Say Medical Device Firm Sees Record Quarterly Revenue Growth, 120% YOY
Source: Streetwise Reports  (11/29/17)
Following the company's release of its latest financial report, three analysts weighed in on the results. More >

Biotech Receives Device Approval in Five More Countries; Revenue Up 122% YOY
Source: Streetwise Reports  (10/25/17)
Maxim Group reported on this firm's Q3/17 earnings, as well as its progress in obtaining international regulatory clearances for its medical system.
More >

Telemedicine Platform Is Quickly Gaining Traction in Fast Growing Market
Source: Streetwise Reports  (10/5/17)
The rapid increase in the incidence of chronic diseases and the need to reduce healthcare costs have led to the growth in telemedicine, which has companies racing to bring new products to market. More >

Maxim Raises Target Price of Biotech Company
Source: Streetwise Reports  (8/16/17)
A year-over-year increase in sales of its flagship product, and the prospect that its technology could be used to promote the efficacy of cell therapies, helped spur a target price increase on this biotech.
More >

Loan Provides Driver for Growth for Medical Device Firm
Source: Streetwise Reports  (8/2/17)
Brian Marckx, analyst with Zacks Small-Cap Research, reports that a $20 million loan received by a U.S.-based medical device company could further fuel growth. More >